National Hemophilia Foundation
Seeking treatment and a cure for, and prevention of, bleeding and clotting disorders.
Based in NY
AI Overview
With $450K in lobbying spend across 9 quarterly filings, National Hemophilia Foundation is an active lobbying client. Their lobbying covers 5 issue areas. Active from 2018 to 2020.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $200K |
| 2019 | $200K |
| 2020 | $50K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that National Hemophilia Foundation disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Medicare/Medicaid, Budget/Appropriations, Insurance, Pharmacy, MED
reimbursement for hemophilia services and treatments; Medicaid reimbursement for treatments for hemophilia patients
Labor-HHS-Appropriations Act for FY 2019
Funding for Hemophilia programs
Implementation of the Affordable Care Act
Issues related to hemophilia treatments, specialty pharmacies and the 340B drug purchasing programs.
Hemophilia research, prevention, surveillance and service programs and issues.
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.